Instructions on the regular purchasing channels and methods of Quizartinib

Quizartinib (Quizartinib is a kinase inhibitor used in combination with standard cytarabine and allium ring induction and cytarabine consolidation, and as maintenance monotherapy after consolidation chemotherapy for the treatment of FLT3 internal tandem duplication (ITD)-positive newly diagnosed acute myeloid leukemia (AML) in adult patients. Quizartinib is not yet available in the Chinese market, and the original drug is purchased mainly through overseas channels. Since it has not yet been approved in China, it cannot be purchased through formal domestic channels. However, patients can obtain quizartinib on the international market through the following channels.

1. Overseas purchasing channels

In overseas markets, especially in Europe and the United States, Quizartinib has been launched and approved as a targeted drug for the treatment of acute myeloid leukemia. Patients can purchase the original drug of Quizartinib through international pharmaceutical agents or legal cross-border e-commerce platforms. Common specifications are 17.7 mg 28 tablets and 26.5 mg 56 tablets. The price fluctuates between RMB 80,000 and RMB 100,000 depending on the exchange rate.

2. Generic drug purchasing channels

In addition to the original drug, there are also generic drugs of Quizartinib on the overseas market. For example, the generic drugs launched by Lucius Pharmaceuticals in Laos are relatively cheap, about more than 1,000 yuan. Although the quality and efficacy of generic drugs are similar to those of brand-name drugs, you still need to be cautious when purchasing them to ensure they come from legitimate sources.

3. Laws and safety of cross-border drug purchase

Since Quizartinib has not yet been approved in China, patients need to understand the relevant laws and regulations when obtaining the drug through cross-border drug purchase. Purchasing foreign drugs in China may face legal risks, so it is recommended to ensure the legality and safety of the source of drugs through legal channels.

In summary, although Quizartinib has not yet been launched in China, patients can still obtain the drug through overseas purchase channels, but they must ensure that the channels are formal when purchasing to ensure the quality and legality of the drug.

Keyword tags: Quizartinib, purchase channels, overseas markets, generic drugs, cross-border drug purchase

References：https://www.drugs.com/mtm/quizartinib.html